Conversations on Cancer Program, Pazdur+25—Celebrating a Silver FDA Anniversary
Join previous FDA Commissioners and the FDA Oncology Center of Excellence, in recognizing a quarter century of federal government service by OCE Center Direc…
Related Articles
Nilotinib Tablets Approved by FDA for Ph+ CML in Chronic Phase
Patients with Philadelphia chromosome–positive CML in chronic phase will no longer be required to fast before taking nilotinib tablets.
2024 Updates in GI Cancer Feature FLOT Combinations, Restricted FDA Approvals by PD-L1 Expression, and More
Yelena Y. Janjigian, MD, highlights key takeaways and data from 2024 in the gastric and GEJ cancer field.
Trump 2016: A look back at the 45th president’s impact on oncology – The Cancer Letter
As oncology contemplates the potential impact of a second Donald Trump term on cancer care and research, The Cancer Letter has compiled a list of…
Clinical Utility of Tumor-Naïve Pre-surgical ctDNA Detection in Early-stage NSCLC
The use of tumor-informed circulating tumor DNA (ctDNA) testing in early-stage patients before surgery is limited mainly due to restricted tissue access and extended turnaround…
PI3K Inhibitor Doubles Breast Cancer PFS
Genentech’s PI3K inhibitor inavolisib (Itovebi) dramatically increased progression-free survival (PFS) in patients with PIK3CA-mutated, hormone receptor–positive, HER2-negative advanced or metastatic breast cancer, according to new…
A Closer Look at Global MGUS Disparity: One Size Does Not Fit All
Multiple myeloma disproportionately affects Black Americans, who are twice as likely to be diagnosed with it and its precursor, monoclonal gammopathy of undetermined significance (MGUS).…
Updates in CLL Treatment: 5-Year Off-Treatment Analyses From the CLL14 and MURANO Trials
This video presents the 5-year off-treatment analyses from the CLL14 and MURANO studies.
Key Learnings from Women Founders In Switzerland
Below are videos of three women entrepreneurs being interviewed by Jim Pulcrano, Professor at IMD
Excellence in Clinical Endocrinology Leadership (ExCEL)
The Excellence in Clinical Endocrinology Leadership (ExCEL) program is now accepting applications. Individuals from diverse backgrounds and underrepresented …
